English

NEUROPACE, INC.

EDGAR

NPCE Quarterly report (10-Q) · filed 2026-08-11

Annual consolidated revenue for 2025: about USD 99.99M, using the latest reported figures. The previous period, 2024, was about USD 79.91M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

22.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 22826000 USD Source

Operating margin

-22.53%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -5143000 USD Source
Revenue: 22826000 USD Source

Operating cash flow

-3.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9800000 USD Source
Operating Cash Flow: -5900000 USD Source

Free cash flow

-4.03 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9800000 USD Source
Operating Cash Flow: -5900000 USD Source
Capital Expenditure: 242000 USD Source
Capital Expenditure: 117000 USD Source

Cash and cash equivalents: 12.5 million USD 2026-06-30 Source
Exact value

12538000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 34.3 million shares 2026-06-30 Source
Exact value

34282567 shares

Reported share-count change

3.75% · 1.24 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33044371 shares · 2025-06-30· Source
34282567 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

98.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 27354000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 99986000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 73398000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 22068000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 22826000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-19.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -3496000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -21465000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -18736000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -6689000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -6200000 USD · 2026-04-01 – 2026-06-30 Source

Capital expenditure

369 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 235000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 205000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 332000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 235000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 117000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 242000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 117000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-11.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+25.1%

Prior period

USD 79.91 million

2024-01-01 – 2024-12-31
Current period

USD 99.99 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

99986000 − 79906000 = 20080000 USD

79906000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
99986000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Year-over-year change in Revenue: 20080000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 99986000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#996506 Filing: 000152828726000011 Input fundies:Revenue: 79906000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#997390 Filing: 000152828726000011
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.68 million

Prior period

−USD 27.14 million

2024-01-01 – 2024-12-31
Current period

−USD 21.47 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-21465000 − -27141000 = 5676000 USD

-27141000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-21465000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Year-over-year change in Net income: 5676000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21465000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1087237 Filing: 000152828726000011 Input fundies:NetIncome: -27141000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1088010 Filing: 000152828726000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.9 million

Prior period

−USD 17.9 million

2024-01-01 – 2024-12-31
Current period

−USD 11 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-11000000 − -17900000 = 6900000 USD

-17900000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-11000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Year-over-year change in Operating cash flow: 6900000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -11000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160324 Filing: 000152828726000011 Input fundies:OperatingCashFlow: -17900000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160508 Filing: 000152828726000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+8.5%

Prior period

USD 306,000

2024-01-01 – 2024-12-31
Current period

USD 332,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

332000 − 306000 = 26000 USD

306000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
332000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Year-over-year change in Capital expenditure: 26000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 332000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1114875 Filing: 000152828726000011 Input fundies:CapitalExpenditure: 306000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1115434 Filing: 000152828726000011
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 99.99 million 100% of revenue
Cost of revenue USD 22.77 million 23% of revenue
Operating expenses USD 93.56 million 94% of revenue
Operating income −USD 16.34 million −16% of revenue
Tax, interest and other Derived USD 5.13 million 5.1% of revenue
Net income −USD 21.47 million −21% of revenue

Cash

Operating cash flow −USD 11 million −11% of revenue
Capital expenditure USD 332,000 0.3% of revenue
Free cash flow Derived −USD 11.33 million −11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 132% of revenue.
2021 Operating loss: operating costs were 153% of revenue.
2022 Operating loss: operating costs were 190% of revenue.
2023 Operating loss: operating costs were 142% of revenue.
2024 Operating loss: operating costs were 127% of revenue.
2025 Operating loss: operating costs were 116% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	41138000	54189000 Derived	-13051000	11227000 Derived	-24278000	-21662000 Derived	Source 2020-01-01 – 2020-12-31: 41138000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -13051000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -24278000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -21600000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 62000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	45183000	68920000 Derived	-23737000	12343000 Derived	-36080000	-24984000 Derived	Source 2021-01-01 – 2021-12-31: 45183000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -23737000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -36080000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -24600000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 384000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	45520000	86314000 Derived	-40794000	6288000 Derived	-47082000	-37503000 Derived	Source 2022-01-01 – 2022-12-31: 45520000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -40794000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -47082000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -36900000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 603000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	65421000	92595000 Derived	-27174000	5782000 Derived	-32956000	-19873000 Derived	Source 2023-01-01 – 2023-12-31: 65421000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -27174000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -32956000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -19700000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 173000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	79906000	101577000 Derived	-21671000	5470000 Derived	-27141000	-18206000 Derived	Source 2024-01-01 – 2024-12-31: 79906000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -21671000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -27141000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -17900000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 306000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	99986000	116324000 Derived	-16338000	5127000 Derived	-21465000	-11332000 Derived	Source 2025-01-01 – 2025-12-31: 99986000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -16338000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -21465000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -11000000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 332000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 100M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	41138000	Revenue: 41138000 Open source
20212021-12-31	Revenue	45183000	Revenue: 45183000 Open source
20222022-12-31	Revenue	45520000	Revenue: 45520000 Open source
20232023-12-31	Revenue	65421000	Revenue: 65421000 Open source
20242024-12-31	Revenue	79906000	Revenue: 79906000 Open source
20252025-12-31	Revenue	99986000	Revenue: 99986000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

25.1% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 41138000 Open source
20212021-12-31	Year over year	9.8%	Revenue: 45183000 Open source Revenue: 41138000 Open source
20222022-12-31	Year over year	0.7%	Revenue: 45520000 Open source Revenue: 45183000 Open source
20232023-12-31	Year over year	43.7%	Revenue: 65421000 Open source Revenue: 45520000 Open source
20242024-12-31	Year over year	22.1%	Revenue: 79906000 Open source Revenue: 65421000 Open source
20252025-12-31	Year over year	25.1%	Revenue: 99986000 Open source Revenue: 79906000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -16.3% 2025

Net margin -21.5% 2025

Free cash flow margin -11.3% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-31.7%	Operating Income: -13051000 Open source Revenue: 41138000 Open source
20212021-12-31	Operating margin	-52.5%	Operating Income: -23737000 Open source Revenue: 45183000 Open source
20222022-12-31	Operating margin	-89.6%	Operating Income: -40794000 Open source Revenue: 45520000 Open source
20232023-12-31	Operating margin	-41.5%	Operating Income: -27174000 Open source Revenue: 65421000 Open source
20242024-12-31	Operating margin	-27.1%	Operating Income: -21671000 Open source Revenue: 79906000 Open source
20252025-12-31	Operating margin	-16.3%	Operating Income: -16338000 Open source Revenue: 99986000 Open source
20202020-12-31	Net margin	-59%	Net Income: -24278000 Open source Revenue: 41138000 Open source
20212021-12-31	Net margin	-79.9%	Net Income: -36080000 Open source Revenue: 45183000 Open source
20222022-12-31	Net margin	-103.4%	Net Income: -47082000 Open source Revenue: 45520000 Open source
20232023-12-31	Net margin	-50.4%	Net Income: -32956000 Open source Revenue: 65421000 Open source
20242024-12-31	Net margin	-34%	Net Income: -27141000 Open source Revenue: 79906000 Open source
20252025-12-31	Net margin	-21.5%	Net Income: -21465000 Open source Revenue: 99986000 Open source
20202020-12-31	Free cash flow margin	-52.7%	Revenue: 41138000 Open source Operating Cash Flow: -21600000 Open source Capital Expenditure: 62000 Open source
20212021-12-31	Free cash flow margin	-55.3%	Revenue: 45183000 Open source Operating Cash Flow: -24600000 Open source Capital Expenditure: 384000 Open source
20222022-12-31	Free cash flow margin	-82.4%	Revenue: 45520000 Open source Operating Cash Flow: -36900000 Open source Capital Expenditure: 603000 Open source
20232023-12-31	Free cash flow margin	-30.4%	Revenue: 65421000 Open source Operating Cash Flow: -19700000 Open source Capital Expenditure: 173000 Open source
20242024-12-31	Free cash flow margin	-22.8%	Revenue: 79906000 Open source Operating Cash Flow: -17900000 Open source Capital Expenditure: 306000 Open source
20252025-12-31	Free cash flow margin	-11.3%	Revenue: 99986000 Open source Operating Cash Flow: -11000000 Open source Capital Expenditure: 332000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -11M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-21600000	Operating Cash Flow: -21600000 Open source
20212021-12-31	Operating cash flow	-24600000	Operating Cash Flow: -24600000 Open source
20222022-12-31	Operating cash flow	-36900000	Operating Cash Flow: -36900000 Open source
20232023-12-31	Operating cash flow	-19700000	Operating Cash Flow: -19700000 Open source
20242024-12-31	Operating cash flow	-17900000	Operating Cash Flow: -17900000 Open source
20252025-12-31	Operating cash flow	-11000000	Operating Cash Flow: -11000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -11.3M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-21662000	Operating Cash Flow: -21600000 Open source Capital Expenditure: 62000 Open source
20212021-12-31	Free cash flow	-24984000	Operating Cash Flow: -24600000 Open source Capital Expenditure: 384000 Open source
20222022-12-31	Free cash flow	-37503000	Operating Cash Flow: -36900000 Open source Capital Expenditure: 603000 Open source
20232023-12-31	Free cash flow	-19873000	Operating Cash Flow: -19700000 Open source Capital Expenditure: 173000 Open source
20242024-12-31	Free cash flow	-18206000	Operating Cash Flow: -17900000 Open source Capital Expenditure: 306000 Open source
20252025-12-31	Free cash flow	-11332000	Operating Cash Flow: -11000000 Open source Capital Expenditure: 332000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

82% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	111.5%	Total Liabilities: 62360000 Open source Total Assets: 55950000 Open source
20212021-12-31	Liabilities / assets	45%	Total Liabilities: 60059000 Open source Total Assets: 133562000 Open source
20222022-12-31	Liabilities / assets	69.5%	Total Liabilities: 79329000 Open source Total Assets: 114106000 Open source
20232023-12-31	Liabilities / assets	80.8%	Total Liabilities: 86997000 Open source Total Assets: 107651000 Open source
20242024-12-31	Liabilities / assets	91.5%	Total Liabilities: 86634000 Open source Total Assets: 94647000 Open source
20252025-12-31	Liabilities / assets	82%	Total Liabilities: 86534000 Open source Total Assets: 105565000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.28× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	5.69×	Current Assets: 54562000 Open source Current Liabilities: 9595000 Open source
20212021-12-31	Current assets / current liabilities	14.28×	Current Assets: 132816000 Open source Current Liabilities: 9301000 Open source
20222022-12-31	Current assets / current liabilities	8.9×	Current Assets: 97714000 Open source Current Liabilities: 10976000 Open source
20232023-12-31	Current assets / current liabilities	5.71×	Current Assets: 92719000 Open source Current Liabilities: 16229000 Open source
20242024-12-31	Current assets / current liabilities	5.37×	Current Assets: 81339000 Open source Current Liabilities: 15156000 Open source
20252025-12-31	Current assets / current liabilities	5.28×	Current Assets: 94073000 Open source Current Liabilities: 17814000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 24.28 million Exact value Exact value: -24278000 USD 2020-01-01 – 2020-12-31: -24278000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2020-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -24278000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24278000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm#2098842 Filing: 000152828722000006 The citation records this snapshot. The page link may show a newer release later.	−USD 21.6 million Exact value Exact value: -21600000 USD 2020-01-01 – 2020-12-31: -21600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2020-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -21600000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm#1438966 Filing: 000152828722000006 The citation records this snapshot. The page link may show a newer release later.	USD 62,000 Exact value Exact value: 62000 USD 2020-01-01 – 2020-12-31: 62000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2020-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 62000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 62000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm#1360516 Filing: 000152828722000006 The citation records this snapshot. The page link may show a newer release later.	−USD 21.66 million Calculation and evidence -21600000 − 62000 USD Exact free cash flow: -21662000 USD 2020-01-01 – 2020-12-31: -21600000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 62000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2020-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -21662000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm#1438966 Filing: 000152828722000006 Input fundies:CapitalExpenditure: 62000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm#1360516 Filing: 000152828722000006 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 36.08 million Exact value Exact value: -36080000 USD 2021-01-01 – 2021-12-31: -36080000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2021-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -36080000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36080000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm#1242742 Filing: 000152828723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 24.6 million Exact value Exact value: -24600000 USD 2021-01-01 – 2021-12-31: -24600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2021-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -24600000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24600000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm#1354270 Filing: 000152828723000007 The citation records this snapshot. The page link may show a newer release later.	USD 384,000 Exact value Exact value: 384000 USD 2021-01-01 – 2021-12-31: 384000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2021-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 384000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm#1285306 Filing: 000152828723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 24.98 million Calculation and evidence -24600000 − 384000 USD Exact free cash flow: -24984000 USD 2021-01-01 – 2021-12-31: -24600000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 384000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2021-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -24984000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24600000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm#1354270 Filing: 000152828723000007 Input fundies:CapitalExpenditure: 384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm#1285306 Filing: 000152828723000007 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 47.08 million Exact value Exact value: -47082000 USD 2022-01-01 – 2022-12-31: -47082000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2022-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -47082000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47082000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm#1127019 Filing: 000152828724000005 The citation records this snapshot. The page link may show a newer release later.	−USD 36.9 million Exact value Exact value: -36900000 USD 2022-01-01 – 2022-12-31: -36900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2022-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -36900000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36900000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm#1193897 Filing: 000152828724000005 The citation records this snapshot. The page link may show a newer release later.	USD 603,000 Exact value Exact value: 603000 USD 2022-01-01 – 2022-12-31: 603000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2022-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 603000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 603000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm#1153207 Filing: 000152828724000005 The citation records this snapshot. The page link may show a newer release later.	−USD 37.5 million Calculation and evidence -36900000 − 603000 USD Exact free cash flow: -37503000 USD 2022-01-01 – 2022-12-31: -36900000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 603000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2022-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -37503000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36900000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm#1193897 Filing: 000152828724000005 Input fundies:CapitalExpenditure: 603000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm#1153207 Filing: 000152828724000005 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 32.96 million Exact value Exact value: -32956000 USD 2023-01-01 – 2023-12-31: -32956000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2023-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -32956000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32956000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm#1082338 Filing: 000152828725000007 The citation records this snapshot. The page link may show a newer release later.	−USD 19.7 million Exact value Exact value: -19700000 USD 2023-01-01 – 2023-12-31: -19700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2023-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -19700000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm#1147827 Filing: 000152828725000007 The citation records this snapshot. The page link may show a newer release later.	USD 173,000 Exact value Exact value: 173000 USD 2023-01-01 – 2023-12-31: 173000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2023-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 173000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 173000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm#1108522 Filing: 000152828725000007 The citation records this snapshot. The page link may show a newer release later.	−USD 19.87 million Calculation and evidence -19700000 − 173000 USD Exact free cash flow: -19873000 USD 2023-01-01 – 2023-12-31: -19700000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 173000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2023-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -19873000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm#1147827 Filing: 000152828725000007 Input fundies:CapitalExpenditure: 173000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm#1108522 Filing: 000152828725000007 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 27.14 million Exact value Exact value: -27141000 USD 2024-01-01 – 2024-12-31: -27141000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2024-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -27141000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27141000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1088010 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 17.9 million Exact value Exact value: -17900000 USD 2024-01-01 – 2024-12-31: -17900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2024-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -17900000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17900000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160508 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	USD 306,000 Exact value Exact value: 306000 USD 2024-01-01 – 2024-12-31: 306000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2024-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 306000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 306000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1115434 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 18.21 million Calculation and evidence -17900000 − 306000 USD Exact free cash flow: -18206000 USD 2024-01-01 – 2024-12-31: -17900000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 306000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2024-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -18206000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17900000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160508 Filing: 000152828726000011 Input fundies:CapitalExpenditure: 306000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1115434 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 21.47 million Exact value Exact value: -21465000 USD 2025-01-01 – 2025-12-31: -21465000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Net Income: -21465000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21465000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1087237 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 11 million Exact value Exact value: -11000000 USD 2025-01-01 – 2025-12-31: -11000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Operating Cash Flow: -11000000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160324 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	USD 332,000 Exact value Exact value: 332000 USD 2025-01-01 – 2025-12-31: 332000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Capital Expenditure: 332000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 332000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1114875 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 11.33 million Calculation and evidence -11000000 − 332000 USD Exact free cash flow: -11332000 USD 2025-01-01 – 2025-12-31: -11000000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 332000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROPACE, INC. · 2025-12-31 NEUROPACE, INC. (edgar:1528287) Free cash flow: -11332000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T04:05:57Z Snapshot: 62020116f14efe1821a44f9e6c385e2627dbbe64fd7a0027659ee04a173ab1a8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1528287?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1160324 Filing: 000152828726000011 Input fundies:CapitalExpenditure: 332000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm#1114875 Filing: 000152828726000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 1,907 latest values · 1,907 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001528287, 1528287, NPCE, edgar:1528287

Also known as NEUROPACE, INC., NeuroPace Inc

NEUROPACE, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation